2024 (2 POSTS)

Munn Z, Pollock D, Stone J, Hasanoff S, Gordon A, Price C, et al. 2024. The impact of using cannabis during pregnancy on the infant and mother: An overview of systematic reviews, evidence map, targeted updates, and de novo synthesis. Austral NZ J Obstet Gynaecol; doi: 10.1111/ajo.13916. Online ahead of print, December 19, 2024.

View Abstract

Rossheim ME, Khoshal B, Karon S, Cheskin L, Trangenstein PJ, Frankenfeld CL, Ramezani N, Cuellar AE. 2024. Substance use and firearm access among college freshmen. J Am Coll Health 72(4):1001-1005; doi: 10.1080/07448481.2022.2068959. PMID: 35549821.

View Abstract

2023 (8 POSTS)

Henderson RG, Vincent M, Rivera BN, Bonn-Miller MO, Doepker C. 2023. Cannabidiol safety considerations: Development of a potential acceptable daily intake value and recommended upper intake limits for dietary supplement use. Regul Toxicol Pharmacol 144(Oct):105482; doi: 10.1016/j.yrtph.2023.105482. PMID: 37634699.

View Abstract

Kulpa J, Lefever TW, Trexler KR, Henderson RG, MacNair L, Toth ML, Vanapalli SA, Rahman M, Gupta S, Bonn-Miller MO. 2023. Toxicity of cannabigerol: Examination of long-term toxicity and lifespan in Caenorhabditis elegans and 14-day study in Sprague Dawley rats. Cannabis Cannabinoid Res 8(S1):S62–S70; doi: 10.1089/can.2023.0035.

View Abstract

Kulpa J, Henderson RG, Schwotzer D, Dye W, Trexler KR, McDonald J, Lefever TW, Bonn-Miller MO. 2023. Toxicological evaluation and pain assessment of four minor cannabinoids following 14-day oral administration in rats. Cannabis Cannabinoid Res 8(S1):S25–S41 doi: 10.1089/can.2023.0049. PMID: 37721989.

View Abstract

Henderson RG, Franke KS, Payne LE, Franzen A. 2023. Cannabidiol safety data: A systematic mapping study. Cannabis Cannabinoid Res 8(1):34–40; doi: 10.1089/can.2022.0100. PMID: 36251454.

View Abstract

Lefever TW, Trexler KR, Henderson RG, Bonn-Miller MO. Pre-clinical evaluation of cannabidiol toxicity in rats. Poster at the 32nd Annual International Cannabinoid Research Society Symposium on the Cannabinoids, Galway, Ireland, June 2022.

Henderson RG, Lefever TW, Heintz MM, Trexler KR, Borghoff SJ, Bonn-Miller MO. 2023. Oral toxicity evaluation of cannabidiol. Food Chem Toxicol 176(June):113786; doi: 10.1016/j.fct.2023.113778. PMID: 37105391.

View Abstract

Henderson RG, Welsh BT, Rogers JM, Borghoff SJ, Trexler KR, Bonn-Miller MO, Lefever TW. 2023. Reproductive and developmental toxicity evaluation of cannabidiol. Food Chem Toxicol 176(June):113786; doi: 10.1016/j.fct.2023.113786. PMID: 37105390.

View Abstract

Henderson RG, Welsh BT, Trexler KR, Bonn-Miller MO, Lefever TW. 2023. Genotoxicity evaluation of cannabidiol. Regul Toxicol Pharmacol 142(August):105425; doi: 10.1016/j.yrtph.2023.105425. PMID: 37271419.

View Abstract

2022 (2 POSTS)

Lefever TW, Schwotzer D, Bonn-Miller MO, McDonald J, Henderson RG, Trexler KR. Novel data update on oral toxicity of phytocannabinoids in rats after 14-days repeated dosing. Carolina Cannabinoid Collaborative (CCC) Conference, Greenville, NC, November 2022.

Swetlik C, Migdady I, Hasan LZ, Buletko AB, Price C, Cho SM. 2022. Cannabis use and stroke: Does a risk exist? J Addict Med, 16(2):208–215; https://doi.org/10.1097/ADM.0000000000000870.

View Abstract

2021 (1 POST)

Franke K, Payne L, Franzen A, Wikoff D, Henderson R. 2021. Cannabidiol literature scoping review protocol. Center for Open Science, OSFHOME (May 20).

View Abstract

2020 (1 POST)

Henderson RG, Franzen A, Franke K, Payne L, Schmitt D, Wikoff D. Creating a literature database for cannabidiol (CBD): Systematic evidence mapping. Poster for Society of Toxicology 59th Annual Meeting, Virtual, 2020.

View Abstract

2019 (1 POST)

Rogers JM, Watanabe M. 2019. Editorial: Special issue on “Developmental effects of smoking, vaping, and cannabis use.” Birth Defects Res 111(17):1245–1247; doi: 10.1002/bdr2.1596.

View Abstract